Medical Letter with Drug and Therapeutics
The Medical Letter, Inc. is committed to providing objective, practical, and timely information on drugs and treatments of common diseases to help our readers make the best decisions for their patients— without the influence of the pharmaceutical industry.
Many of our readers know that pharmaceutical companies and their representatives often exaggerate the therapeutic effects and understate the adverse effects of their products, but busy practitioners have neither the time nor the resources to check the accuracy of the manufacturers’ claims. Our publication is intended specifically to meet the needs of busy healthcare professionals who want unbiased, reliable, and timely drug information. Our editorial process is designed to ensure that the information we provide represents an unbiased consensus of medical experts.
The Medical Letter on Drugs and Therapeutics
- 26 issues per year: online and with our mobile app. Includes past issues (1988-present)
- Evidence-based, peer-reviewed evaluations of new FDA-approved drugs with conclusions reached by a
- consensus of experts
- Our signature tables and charts that make comparing drugs quick and easy
- Comparative reviews and recommendations of all of the preferred and alternative treatments for a given indication with particular attention to clinical efficacy, adverse effects, drug interactions, and cost.